Evidence-Based Medicine Guidelines
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Transarterial (chemo)embolisation for Unresectable Hepatocellular Carcinoma." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457578/all/Transarterial__chemo_embolisation_for_unresectable_hepatocellular_carcinoma.
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457578/all/Transarterial__chemo_embolisation_for_unresectable_hepatocellular_carcinoma. Accessed May 28, 2023.
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457578/all/Transarterial__chemo_embolisation_for_unresectable_hepatocellular_carcinoma
Transarterial (chemo)embolisation for Unresectable Hepatocellular Carcinoma [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 May 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457578/all/Transarterial__chemo_embolisation_for_unresectable_hepatocellular_carcinoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
ID - 457578
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457578/all/Transarterial__chemo_embolisation_for_unresectable_hepatocellular_carcinoma
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
